Herbalife Nutrition (NYSE:HLF) PT Lowered to $41.00


Herbalife Nutrition (NYSE:HLFGet Rating) had its price target dropped by investment analysts at B. Riley from $50.00 to $41.00 in a report issued on Wednesday, The Fly reports. B. Riley’s target price would suggest a potential upside of 48.71% from the stock’s previous close.

Other research analysts also recently issued reports about the company. Zacks Investment Research upgraded Herbalife Nutrition from a “sell” rating to a “hold” rating in a report on Tuesday, April 26th. StockNews.com upgraded Herbalife Nutrition from a “hold” rating to a “buy” rating in a report on Sunday, April 10th. Jefferies Financial Group downgraded Herbalife Nutrition from a “buy” rating to a “hold” rating and cut their price target for the company from $60.00 to $26.00 in a report on Wednesday. Finally, Citigroup cut their price target on Herbalife Nutrition from $46.00 to $36.00 in a report on Wednesday. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $39.50.

HLF opened at $27.57 on Wednesday. The stock’s fifty day moving average is $31.48 and its two-hundred day moving average is $38.30. The company has a market capitalization of $3.03 billion, a P/E ratio of 6.72 and a beta of 1.07. Herbalife Nutrition has a 52 week low of $25.57 and a 52 week high of $55.78.

Herbalife Nutrition (NYSE:HLFGet Rating) last released its quarterly earnings data on Tuesday, May 3rd. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.90 by $0.09. The company had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.38 billion. Herbalife Nutrition had a negative return on equity of 38.29% and a net margin of 7.71%. Herbalife Nutrition’s quarterly revenue was down 11.1% on a year-over-year basis. During the same period last year, the business posted $1.42 EPS. Equities analysts anticipate that Herbalife Nutrition will post 4.21 EPS for the current year.

A number of hedge funds have recently made changes to their positions in the stock. Route One Investment Company L.P. grew its stake in Herbalife Nutrition by 3.7% during the 4th quarter. Route One Investment Company L.P. now owns 9,112,732 shares of the company’s stock worth $372,984,000 after buying an additional 321,500 shares during the last quarter. BlackRock Inc. grew its stake in Herbalife Nutrition by 0.9% during the 4th quarter. BlackRock Inc. now owns 4,223,794 shares of the company’s stock worth $172,881,000 after buying an additional 38,740 shares during the last quarter. Deccan Value Investors L.P. grew its stake in Herbalife Nutrition by 26.3% during the 3rd quarter. Deccan Value Investors L.P. now owns 3,745,293 shares of the company’s stock worth $158,726,000 after buying an additional 780,218 shares during the last quarter. CAS Investment Partners LLC grew its stake in Herbalife Nutrition by 2.2% during the 4th quarter. CAS Investment Partners LLC now owns 3,062,762 shares of the company’s stock worth $125,359,000 after buying an additional 66,300 shares during the last quarter. Finally, Bronte Capital Management Pty Ltd. grew its stake in Herbalife Nutrition by 17.5% during the 4th quarter. Bronte Capital Management Pty Ltd. now owns 2,755,572 shares of the company’s stock worth $112,786,000 after buying an additional 410,086 shares during the last quarter.

About Herbalife Nutrition (Get Rating)

Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and rest of Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.

Featured Articles



Receive News & Ratings for Herbalife Nutrition Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Herbalife Nutrition and related companies with MarketBeat.com’s FREE daily email newsletter.

Exit mobile version